ArticleNagoya journal of medical science2025

Durvalumab-combined chemotherapy for biliary tract cancer in a Japanese expert center: initial 50 cases in daily practice.

Yoshikuni Inokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.